Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro

Cancers
Rodolfo Garza-MoralesJorge G Gomez-Gutierrez

Abstract

Triple-negative breast cancer (TNBC) is one of the most aggressive types of cancer, and treatment is limited to chemotherapy and radiation. Oncolytic virotherapy may be a promising approach to treat TNBC. However, oncolytic adenovirus (OAd)-based mono-therapeutic clinical trials have resulted in modest outcomes. The OAd potency could be increased by chemotherapy-induced autophagy, an intracellular degradation system that delivers cytoplasmic constituents to the lysosome. In this study, the ability of alkylating agent temozolomide (TMZ)-induced autophagy to increase OAd replication and oncolysis in TNBC cells was evaluated. Human TNBC MDA-MB-231 and HCC1937 cells and mouse 4T1 cells were infected with an OAd expressing the red fluorescent protein mCherry on the virus capsid (OAdmCherry) alone or in combination with TMZ. TNBC cells treated with OAdmCherry/TMZ displayed greater mCherry and adenovirus (Ad) early region 1A (E1A) expression and enhanced cancer-cell killing compared to OAdmCherry or TMZ alone. The combined therapy-mediated cell death was associated with virus replication and accumulation of the autophagy marker light chain 3 (LC3)-II. Overall, this study provides experimental evidence of TMZ's ability to increase onco...Continue Reading

References

Mar 11, 2000·Drugs·J A O'Shaughnessy
Mar 28, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M E TrudeauE Eisenhauer
Jul 25, 2006·Cancer Biology & Therapy·Jorge G Gomez-GutierrezKelly M McMasters
Mar 7, 2007·Current Topics in Developmental Biology·Devrim Gozuacik, Adi Kimchi
Apr 5, 2007·Nature Protocols·Nicolaas A P FrankenChris van Bree
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
May 27, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ta-Chiang LiuDavid H Kirn
Aug 6, 2008·Methods in Molecular Biology·Ta-Chiang LiuDavid H Kirn
Apr 14, 2009·Cancer Gene Therapy·L N KaliberovaS A Kaliberov
May 12, 2009·Autophagy·Matthew A TylerMaciej S Lesniak
Jul 29, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anniina KoskiAkseli Hemminki
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
May 18, 2011·Virology·Humberto Rodriguez-RochaHeshan Sam Zhou
Jun 29, 2011·International Journal of Cancer. Journal International Du Cancer·Regina HolzmüllerPer S Holm
Jul 24, 2012·Cancer Treatment Reviews·Zuzana TatarXavier Durando
Apr 3, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ilkka LiikanenAkseli Hemminki
Aug 12, 2014·Journal of Cancer Research and Clinical Oncology·Guan JiangYan-Qun Liu
Sep 23, 2014·Human Gene Therapy. Clinical Development·Michael E EggerJorge G Gomez-Gutierrez
Oct 19, 2016·Nature Reviews. Clinical Oncology·Giampaolo BianchiniLuca Gianni
Oct 25, 2016·Biochimica Et Biophysica Acta·Otília MenyhártBalázs Győrffy
Nov 21, 2016·Lancet·Nadia Harbeck, Michael Gnant
Jul 3, 2017·The Breast : Official Journal of the European Society of Mastology·Lironne Wein, Sherene Loi
Dec 19, 2017·Cancer Biology & Therapy·Rodolfo Garza-MoralesJorge G Gomez-Gutierrez

❮ Previous
Next ❯

Citations

Aug 8, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bharath Kumar VelmuruganChing-Feng Weng
May 28, 2020·Journal for Immunotherapy of Cancer·Dipongkor SahaRobert L Martuza
Aug 18, 2020·Expert Opinion on Biological Therapy·Wei ZhangJianfang Ning
Mar 7, 2021·Cancers·Hong-My NguyenDipongkor Saha
Jun 21, 2020·Anti-cancer Agents in Medicinal Chemistry·Milad AshrafizadehAmirhossein Sahebkar
Jan 5, 2022·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·William M MacCuaigLacey R McNally

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
fluorescence microscopy

Software Mentioned

pro Analyzer
Gel

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.